Assyro AI

Orange Book product · Generic (ANDA)

BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE

ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Generic (ANDA)ANDA 075351DISCN NOVITIUM PHARMA

At a glance

Mar 05, 1999

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 05, 1999

    27 yr 8 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Strength

325MG;50MG;40MG;30MG

Dosage form

CAPSULE

Route

ORAL

TE code

Not listed

Application

ANDA 075351

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ASPIRIN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.